BlackRock’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
|
|||||
|
2025
Q1 | $8.44M | Sell |
|
|||||
|
2024
Q4 | $18.1M | Buy |
|
|||||
|
2024
Q3 | $36.7M | Buy |
|
|||||
|
2024
Q2 | $33.2M | Buy |
|
|||||
|
2024
Q1 | $66.8M | Sell |
|
|||||
|
2023
Q4 | $41.9M | Sell |
|
|||||
|
2023
Q3 | $26.5M | Buy |
|
|||||
|
2023
Q2 | $57M | Buy |
|
|||||
|
2023
Q1 | $65.4M | Buy |
|
|||||
|
2022
Q4 | $98.1M | Buy |
|
|||||
|
2022
Q3 | $177M | Buy |
|
|||||
|
2022
Q2 | $184M | Buy |
|
|||||
|
2022
Q1 | $275M | Buy |
|
|||||
|
2021
Q4 | $413M | Buy |
|
|||||
|
2021
Q3 | $397M | Buy |
|
|||||
|
2021
Q2 | $572M | Sell |
|
|||||
|
2021
Q1 | $591M | Buy |
|
|||||
|
2020
Q4 | $607M | Buy |
|
|||||
|
2020
Q3 | $262M | Buy |
|
|||||
|
2020
Q2 | $209M | Buy |
|
|||||
|
2020
Q1 | $124M | Sell |
|
|||||
|
2019
Q4 | $113M | Buy |
|
|||||
|
2019
Q3 | $81.7M | Buy |
|
|||||
|
2019
Q2 | $105M | Sell |
|
|||||
|
2019
Q1 | $91.2M | Buy |
|
|||||
|
2018
Q4 | $64.6M | Buy |
|
|||||
|
2018
Q3 | $56.5M | Buy |
|
|||||
|
2018
Q2 | $37.3M | Buy |
|
|||||
|
2018
Q1 | $28.3M | Buy |
|
|||||
|
2017
Q4 | $10.4M | Buy |
|
|||||
|
2017
Q3 | $6.58M | Buy |
|
|||||
|
2017
Q2 | $5.38M | Buy |
|
|||||
|
2017
Q1 | $392K | Buy |
|